ArticleRadiology and oncology2026

Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab.

Peter Popovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.